Your browser doesn't support javascript.
loading
2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis.
Ehlers, Lisa; Askling, Johan; Bijlsma, Hans Wj; Cid, Maria Cinta; Cutolo, Maurizio; Dasgupta, Bhaskar; Dejaco, Christian; Dixon, William G; Feltelius, Nils; Finckh, Axel; Gilbert, Kate; Mackie, Sarah Louise; Mahr, Alfred; Matteson, Eric L; Neill, Lorna; Salvarani, Carlo; Schmidt, Wolfgang A; Strangfeld, Anja; van Vollenhoven, Ronald F; Buttgereit, Frank.
Affiliation
  • Ehlers L; Department of Rheumatology and Clinical Immunology, Charité University Medicine Berlin, Berlin, Germany lisa.ehlers@charite.de.
  • Askling J; Department of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden.
  • Bijlsma HW; Rheumatology, UMC Utrecht, Utrecht, Netherlands.
  • Cid MC; Department of Autoimmune Diseases, Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
  • Cutolo M; Department Internal Medicine University of Genova, Research Laboratory and Academic Clinical Unit of Rheumatology, Viale Benedetto, Italy.
  • Dasgupta B; Rheumatology, Southend Hospital NHS Trust, Westcliff-on-Sea, UK.
  • Dejaco C; Rheumatology, Medical University Graz, Graz, Austria.
  • Dixon WG; Rheumatology, Hospital Of Bruneck, Bruneck, Italy.
  • Feltelius N; Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, UK.
  • Finckh A; Medical Products Agency, Uppsala, Sweden.
  • Gilbert K; Cross-Committee Task Force on Registries at the European Medicines Agency, London, UK.
  • Mackie SL; Division of Rheumatology, University of Geneva, Geneva, Switzerland.
  • Mahr A; PMRGCAuk, London, UK.
  • Matteson EL; UK and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
  • Neill L; Department of Internal Medicine, Hospital Saint-Louis, University Paris Diderot, Paris, France.
  • Salvarani C; Division of Rheumatology and Department of Health Sciences Research, Mayo Clinic, Rochester, New York, USA.
  • Schmidt WA; Patient Charity Polymyalgia Rheumatica and Giant Cell Arteritis Scotland, Dundee, UK.
  • Strangfeld A; Division of Rheumatology, Azienda Ospedaliera IRCCS di Reggio Emilia and University of Modena and Reggio Emilia, Modena, Italy.
  • van Vollenhoven RF; Rheumatology, Medical Centre for Rheumatology Berlin Buch, Berlin, Germany.
  • Buttgereit F; Forschungsbereich Epidemiologie, Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany.
Ann Rheum Dis ; 78(9): 1160-1166, 2019 09.
Article in En | MEDLINE | ID: mdl-30898837
ABSTRACT
Giant cell arteritis (GCA) represents the most common form of primary systemic vasculitis and is frequently associated with comorbidities related to the disease itself or induced by the treatment. Systematically collected data on disease course, treatment and outcomes of GCA remain scarce. The aim of this EULAR Task Force was to identify a core set of items which can easily be collected by experienced clinicians, in order to facilitate collaborative research into the course and outcomes of GCA. A multidisciplinary EULAR task force group of 20 experts including rheumatologists, internists, epidemiologists and patient representatives was assembled. During a 1-day meeting, breakout groups discussed items from a previously compiled collection of parameters describing GCA status and disease course. Feedback from breakout groups was further discussed. Final consensus was achieved by means of several rounds of email discussions after the meeting. A three-round Delphi survey was conducted to determine a core set of parameters including the level of agreement. 117 parameters were regarded as relevant. Potential items were subdivided into the following categories General, demographics, GCA-related signs and symptoms, other medical conditions and treatment. Possible instruments and assessment intervals were proposed for documentation of each item. To facilitate implementation of the recommendations in clinical care and clinical research, a minimum core set of 50 parameters was agreed. This proposed core set intends to ensure that relevant items from different GCA registries and databases can be compared for the dual purposes of facilitating clinical research and improving clinical care.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Rheumatology / Societies, Medical / Giant Cell Arteritis / Practice Guidelines as Topic / Delivery of Health Care / Biomedical Research Type of study: Guideline / Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Ann Rheum Dis Year: 2019 Type: Article Affiliation country: Germany

Full text: 1 Database: MEDLINE Main subject: Rheumatology / Societies, Medical / Giant Cell Arteritis / Practice Guidelines as Topic / Delivery of Health Care / Biomedical Research Type of study: Guideline / Prognostic_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Ann Rheum Dis Year: 2019 Type: Article Affiliation country: Germany